1. Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma

   Saba, K. H., Cornmark, L., Hofvander, J., Magnusson, L., Nilsson, J., van den Bos, H., Spierings, D. C., Foijer, F., Staaf, J., Brosjö, O., Sumathi, V. P., Lam, S. W., Szuhai, K., Bovée, J. V., Kovac, M., Baumhoer, D., Styring, E. & Nord, K. H., 16-Jun-2020, In : Journal of pathology clinical research. 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non-small cell lung cancer

   Theelen, W. S., Mittempergher, L., Willems, S. M., Bosma, A. J., Peters, D. D., van der Noort, V., Japenga, E. J., Peeters, T., Koole, K., Šuštić, T., Blaauwgeers, J. L., van Noesel, C. J., Bernards, R. & van den Heuvel, M. M., 2016, In : Journal of pathology clinical research. 2, 4, p. 223-233 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessment

   Warram, J. M., de Boer, E., van Dam, G. M., Moore, L. S., Bevans, S. L., Walsh, E. M., Young, E. S., Carroll, W. R., Stevens, T. M. & Rosenthal, E. L., Apr-2016, In : Journal of pathology clinical research. 2, 2, p. 104-112 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (3) »